Streetbeat News

Products Services

EGP

EastGroup Properties (EGP) has acquired a property in Atlanta, reflecting its expansion strategy in the Sunbelt's shallow bay industrial market. This move aligns with broader trends in the industrial real estate sector, indicating healthy leasing activity.

Portfolio Pulse from

November 15, 2024 | 4:30 pm

ALT

Altimmune presented new data at The Liver Meeting® 2024 showing that weekly subcutaneous doses of pemvidutide significantly reduce inflammatory lipids in subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Portfolio Pulse from

November 15, 2024 | 4:15 pm

ABUS

Arbutus and Barinthus Bio have announced new data from the IM-PROVE II trial, indicating that the addition of Nivolumab increased rates of HBsAg loss in chronic Hepatitis B patients. This suggests potential advancements in treatment options.

Portfolio Pulse from

November 15, 2024 | 4:15 pm

BROS

The article discusses the growing obsession of Americans with iced coffee, highlighting cultural and lifestyle factors driving this trend.

Portfolio Pulse from

November 15, 2024 | 4:15 pm

AKRO

Akero Therapeutics will present new analyses from its Phase 2b HARMONY study at the 75th Annual AASLD The Liver Meeting® 2024. The study showed significant regression of liver fibrosis in over 40% of participants treated with EFX 50mg for 96 weeks, compared to 0% for placebo.

Portfolio Pulse from

November 15, 2024 | 4:15 pm

HD

Home Depot has acquired SRS Distribution for $18.25 billion to strengthen its position in the professional business sector, despite slow home improvement demand.

Portfolio Pulse from

November 15, 2024 | 4:15 pm

VIR

Vir Biotechnology announced positive results from the MARCH Phase 2 study on hepatitis B treatments, showing promising seroclearance rates with tobevibart and elebsiran combinations.

Portfolio Pulse from

November 15, 2024 | 4:15 pm

ABUS

BRNS

Arbutus and Barinthus Bio have announced new data from the IM-PROVE II trial, indicating that the addition of Nivolumab increased rates of HBsAg loss in people with chronic Hepatitis B.

Portfolio Pulse from

November 15, 2024 | 4:15 pm

BKNG

Booking Holdings (BKNG) shares have risen 40% year-to-date, driven by an expanding clientele and AI integration.

Portfolio Pulse from

November 15, 2024 | 4:15 pm

AVIR

Atea Pharmaceuticals presented new data at The Liver Meeting 2024 supporting the combination of bemnifosbuvir and ruzasvir for treating Hepatitis C. The combination is in Phase 2 development.

Portfolio Pulse from

November 15, 2024 | 4:15 pm